Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Manic pseudodementia: case report.

H W Koenigsberg

    The Journal of Clinical Psychiatry
    |March 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Toward an animal model of borderline personality disorder.

    Psychopharmacology·2019
    Same author

    Severe childhood trauma and clinical and neurocognitive features in schizotypal personality disorder.

    Acta psychiatrica Scandinavica·2019
    Same author

    A method for analyzing therapist interventions in the psychotherapy of borderline patients.

    The Journal of psychotherapy practice and research·2012
    Same author

    The combination of psychotherapy and pharmacotherapy in the treatment of borderline patients.

    The Journal of psychotherapy practice and research·2012
    Same author

    Predictors of dropout in psychodynamic psychotherapy of borderline personality disorder.

    The Journal of psychotherapy practice and research·2012
    Same author

    Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences.

    Journal of psychiatric research·2001
    Same journal

    Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

    The Journal of clinical psychiatry·2026
    Same journal

    Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

    The Journal of clinical psychiatry·2026
    Same journal

    Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

    The Journal of clinical psychiatry·2026
    Same journal

    Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

    The Journal of clinical psychiatry·2026
    See all related articles

    This article describes a 48-year-old woman who initially appeared to have cognitive decline but was later diagnosed with bipolar disorder. Her memory and thinking problems improved significantly after she received lithium treatment. The report suggests that underlying, silent neurological issues might make some psychiatric conditions look like dementia.

    Area of Science:

    • Psychiatry and clinical neurology research regarding manic pseudodementia
    • Neuropsychology and cognitive assessment in mood disorders

    Background:

    Clinicians often struggle to distinguish between primary cognitive decline and psychiatric conditions that mimic memory loss. No prior work had fully resolved why some patients with mood disturbances present with significant cognitive deficits. That uncertainty drove interest in identifying specific clinical markers for reversible cognitive impairment. It was already known that bipolar illness can sometimes manifest with symptoms resembling dementia. This gap motivated a closer look at how psychiatric diagnoses evolve over time in hospitalized individuals. Prior research has shown that cognitive testing can help differentiate between organic brain syndrome and functional psychiatric disorders. However, the exact relationship between mood instability and cognitive performance remains a subject of ongoing investigation. This report addresses the need for detailed documentation of cognitive recovery following mood stabilization.

    Purpose Of The Study:

    The aim of this report is to illustrate the occurrence of pseudodementia within the context of bipolar illness. This study addresses the diagnostic challenges posed by patients presenting with apparent cognitive decline. The authors seek to clarify the relationship between mood instability and cognitive dysfunction in a clinical setting. This work explores why some psychiatric patients are initially misdiagnosed with organic brain syndrome. The motivation stems from the need to improve diagnostic accuracy for complex psychiatric presentations. By documenting this specific case, the researchers intend to highlight the potential for reversible cognitive impairment. The study examines how pharmacological intervention can influence cognitive outcomes in patients with mood disorders. This investigation provides a foundation for understanding the intersection of psychiatric and cognitive symptoms.

    Keywords:
    cognitive impairmentmood disorderslithium carbonateneuropsychological assessment

    Frequently Asked Questions

    The researchers propose that the patient's cognitive deficits were a manifestation of bipolar illness rather than a permanent organic condition. Lithium carbonate treatment led to a documented improvement in her neuropsychologic test scores, suggesting the impairment was reversible.

    The authors utilized clinical observation alongside standardized neuropsychologic testing to track changes. These tools allowed for the objective documentation of the patient's cognitive state before and after the administration of lithium carbonate.

    The authors suggest that a preexisting subclinical neurologic disorder might be necessary to facilitate this specific presentation. This underlying condition potentially interacts with the psychiatric illness to produce symptoms that mimic dementia.

    Neuropsychologic testing served as the primary data source for quantifying cognitive performance. This information was vital for distinguishing between the initial diagnosis of organic brain syndrome and the later identification of bipolar disorder.

    Related Experiment Videos

    Main Methods:

    The review approach involved a detailed longitudinal analysis of a single patient case. Investigators gathered data through direct clinical observation during the entire period of hospitalization. They performed serial neuropsychologic assessments to evaluate cognitive function at different stages of the illness. The team tracked the patient's response to lithium carbonate therapy over several weeks. This methodology focused on comparing cognitive performance before and after mood stabilization. The authors synthesized findings from both psychiatric evaluations and cognitive testing batteries. They examined the patient's medical history to identify potential contributing factors for her cognitive state. This systematic review approach allowed for a comprehensive description of the clinical trajectory observed in this individual.

    Main Results:

    Key findings from the literature indicate that the patient's cognitive deficits were highly responsive to lithium carbonate treatment. The initial assessment suggested an organic brain syndrome, but subsequent evaluations confirmed a diagnosis of bipolar illness. The patient demonstrated a clear improvement in cognitive performance following the stabilization of her mood. This case demonstrates that cognitive impairment can be a transient feature of bipolar disorder. The authors documented that the patient's memory and executive functions returned to expected levels after therapy. These results suggest that the observed pseudodementia was secondary to the underlying psychiatric condition. The data show a direct correlation between the reduction of manic symptoms and the resolution of cognitive deficits. This finding highlights the potential for misdiagnosis when cognitive symptoms are evaluated in isolation.

    Conclusions:

    The authors propose that pseudodementia may serve as a clinical presentation for underlying bipolar illness. Their observations suggest that cognitive deficits in this context can be reversible with appropriate mood-stabilizing therapy. The report highlights the potential role of lithium carbonate in restoring cognitive function for these specific patients. Synthesis and implications indicate that clinicians should consider mood disorders when evaluating patients with apparent cognitive decline. The findings support the idea that subclinical neurologic issues might predispose individuals to this specific presentation. This synthesis suggests that neuropsychologic testing provides a valuable tool for tracking patient progress during treatment. The authors emphasize that psychiatric symptoms can mask cognitive health in complex clinical scenarios. These implications underscore the importance of accurate diagnostic reassessment in patients showing signs of cognitive impairment.

    The patient exhibited significant cognitive impairments that were initially misattributed to organic brain syndrome. These deficits were measured through clinical assessments and formal testing, which showed a positive response to pharmacological intervention.

    The researchers propose that clinicians should remain vigilant for bipolar illness when patients present with pseudodementia. They suggest that early identification and treatment of the underlying mood disorder can lead to significant cognitive recovery.